To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM

This trial tests whether a combination cholesterol medication (Ezefeno, combining ezetimibe and fenofibrate) safely lowers non-HDL cholesterol and triglycerides in people with Type 2 diabetes and high cardiovascular risk. **You may be eligible if...** - You have been diagnosed with Type 2 diabetes - You are 19 years or older - Your non-HDL cholesterol is 100 mg/dL or higher and your triglycerides are between 200–500 mg/dL while on moderate-intensity statin therapy - You have at least one cardiovascular risk factor **You may NOT be eligible if...** - You are pregnant or breastfeeding - Your blood sugar is very poorly controlled (HbA1c above 12%) - You have muscle disease (myopathy or rhabdomyolysis) - Your liver enzymes are more than 3 times the upper limit of normal - You have certain rare genetic conditions affecting sugar or lactose metabolism Talk to your doctor to see if this trial is right for you.